|
Taking pleasure in the long and fruitful association with the New York Cardiac Center,
Professor Thomas J.
Brady, Director of Radiology Research, acknowledges the participation
provided by the NYCC in the
NMR Centers cardiac research initiative. The program is
designed to develop and evaluate new CT/MR-based techniques that measure the condition of the
cardiovascular system with an ultimate goal being the implementation of a suite of routine
diagnostic tools for the clinician to achieve better diagnoses and treatment plans.
The first project association concentrated on developing protocols and methodologies for
individual diagnostic MR-based procedures. These developments included: 1) Time of Flight
flow imaging to measure the velocity of coronary blood flow, 2) Susceptibility imaging
a technique to provide information on myocardial perfusion, and 3) Strain-MR
methods to measure cardiac function. These tools individually provide significant
diagnostic information and when used in concert, through an Integrated
CT/MR-based Cardiac
Examination, have the potential to replace a series of expensive "gold standard"
examinations with one cost-effective procedure. Realizing this potential will be a
significant clinical advance. In a second project association, the development of these MR
protocols was developed further and a series of limited clinical trials further evaluated
the efficacy of these MR-based methods.
The ongoing effort continues development of the diagnostic capabilities of the
CT/MR
techniques through extensive clinical trials. These studies are designed to further
validate research protocols measuring coronary flow, perfusion, atheroma characterization
and cardiac architecture. They will lead to a better understanding of what heart failure
is and the effects of the disease process on the heart.
Dr. Brady, "
commends the New York Cardiac Center for its foresight in
participating in cardiac magnetic resonance imaging research, at Massachusetts General
Hospital-CIMIT, at a time when this technology was considered inadequate to provide
clinical data for cardiac diagnoses. The rapidly developing technologies coupled with
advances in imaging methodologies have made it a leading contender as a diagnostic tool in
the clinician armamentarium."
---------------------------------------------------------------------------------------------------------------------------------
To learn more about NYCC projects call us at (201) 569-8180, fax us at (201)
568-5571
or write to us at: 82 North Summit Street, Tenafly, NJ 07670.
Home | Uptam | Cardio-Education | Trans-Immune at Yale | Mri at Harvard | About
NYCC|Memorials
Copyright © NYCC 2000
|